Albion Technology & Gen VCT (AATG) Competitors GBX 68.50 0.00 (0.00%) As of 09/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock AATG vs. BPCR, JPE, TRY, TMPL, BBGI, OCI, JEO, APEO, ICGT, and MUTShould you be buying Albion Technology & Gen VCT stock or one of its competitors? The main competitors of Albion Technology & Gen VCT include BioPharma Credit (BPCR), JPMorgan Elect plc - Managed Growth (JPE), TR Property Investment Trust (TRY), Temple Bar (TMPL), BBGI Global Infrastructure (BBGI), Oakley Capital Investments (OCI), European Opportunities Trust (JEO), abrdn Private Equity Opportunities (APEO), ICG Enterprise Trust (ICGT), and Murray Income Trust (MUT). These companies are all part of the "asset management" industry. Albion Technology & Gen VCT vs. Its Competitors BioPharma Credit JPMorgan Elect plc - Managed Growth TR Property Investment Trust Temple Bar BBGI Global Infrastructure Oakley Capital Investments European Opportunities Trust abrdn Private Equity Opportunities ICG Enterprise Trust Murray Income Trust Albion Technology & Gen VCT (LON:AATG) and BioPharma Credit (LON:BPCR) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Which has preferable earnings and valuation, AATG or BPCR? BioPharma Credit has higher revenue and earnings than Albion Technology & Gen VCT. BioPharma Credit is trading at a lower price-to-earnings ratio than Albion Technology & Gen VCT, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlbion Technology & Gen VCT£12.51M20.81£5.59M£0.061,155.14BioPharma Credit£124.46M0.08£10.42B£0.109.13 Is AATG or BPCR more profitable? BioPharma Credit has a net margin of 80.20% compared to Albion Technology & Gen VCT's net margin of 62.22%. BioPharma Credit's return on equity of 8.51% beat Albion Technology & Gen VCT's return on equity.Company Net Margins Return on Equity Return on Assets Albion Technology & Gen VCT62.22% 3.99% 2.17% BioPharma Credit 80.20%8.51%4.98% Do institutionals and insiders hold more shares of AATG or BPCR? 21.4% of BioPharma Credit shares are held by institutional investors. 0.3% of Albion Technology & Gen VCT shares are held by company insiders. Comparatively, 0.1% of BioPharma Credit shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is AATG or BPCR a better dividend stock? Albion Technology & Gen VCT pays an annual dividend of GBX 0.04 per share and has a dividend yield of 0.1%. BioPharma Credit pays an annual dividend of GBX 0.07 per share and has a dividend yield of 7.7%. Albion Technology & Gen VCT pays out 62.1% of its earnings in the form of a dividend. BioPharma Credit pays out 70.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the media prefer AATG or BPCR? In the previous week, Albion Technology & Gen VCT's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score. Company Overall Sentiment Albion Technology & Gen VCT Neutral BioPharma Credit Neutral SummaryBioPharma Credit beats Albion Technology & Gen VCT on 8 of the 12 factors compared between the two stocks. Get Albion Technology & Gen VCT News Delivered to You Automatically Sign up to receive the latest news and ratings for AATG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AATG vs. The Competition Export to ExcelMetricAlbion Technology & Gen VCTAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£260.33M£1.45B£6.38B£2.58BDividend Yield5.42%4.59%4.31%5.30%P/E Ratio1,155.144,744.741,773.825,404.14Price / Sales20.811,957.931,352.5496,701.95Price / Cash3.2860.6248.9927.93Price / Book0.881.372.078.78Net Income£5.59M£265.04M£1.23B£5.89B7 Day PerformanceN/A0.52%1.07%0.56%1 Month Performance-2.14%1.39%1.78%44.71%1 Year Performance-3.52%8.76%32.11%174.03% Albion Technology & Gen VCT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AATGAlbion Technology & Gen VCTN/AGBX 68.50flatN/AN/A£260.33M£12.51M1,155.14N/ABPCRBioPharma CreditN/AGBX 0.91flatN/A+3.2%£1.03B£124.46M9.11N/AJPEJPMorgan Elect plc - Managed GrowthN/AN/AN/AN/A£1.00B£104.78M1,250.00N/ATRYTR Property Investment TrustN/AGBX 316+0.5%N/A-11.5%£998.07M-£19.36M-3,653.1826Positive NewsTMPLTemple BarN/AGBX 348.50-0.1%N/A+33.0%£991.85M£168.39M606.09N/ANews CoverageBBGIBBGI Global InfrastructureN/AGBX 138.50flatN/AN/A£984.71M£67.98M17.931,160OCIOakley Capital InvestmentsN/AGBX 565+0.5%N/A+12.1%£961.99M£32.33M376,666.67N/AEarnings ReportJEOEuropean Opportunities TrustN/AN/AN/AN/A£886.70M-£62.33M-12.93N/AAPEOabrdn Private Equity OpportunitiesN/AN/AN/AN/A£880.29M£80.21M1,435.00N/AICGTICG Enterprise TrustN/AGBX 1,396-0.4%N/A+15.4%£877.72M£117.70M852.21N/AMUTMurray Income TrustN/AGBX 900+0.4%N/A+4.7%£877.11M£27.79M3,703.70147,000News CoveragePositive NewsEarnings ReportDividend Cut Related Companies and Tools Related Companies BioPharma Credit Alternatives JPMorgan Elect plc - Managed Growth Alternatives TR Property Investment Trust Alternatives Temple Bar Alternatives BBGI Global Infrastructure Alternatives Oakley Capital Investments Alternatives European Opportunities Trust Alternatives abrdn Private Equity Opportunities Alternatives ICG Enterprise Trust Alternatives Murray Income Trust Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:AATG) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Albion Technology & Gen VCT Please log in to your account or sign up in order to add this asset to your watchlist. Share Albion Technology & Gen VCT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
